Trupanion (NASDAQ:TRUP) Shares Gap Up - Here's What Happened

Trupanion logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Trupanion shares opened higher at $35.88, up from the previous close of $34.48, and later traded at $35.63.
  • The company beat quarterly estimates, reporting EPS of $0.21 versus $0.17 expected and revenue of $405.6 million versus $402.5 million expected.
  • Analyst sentiment remained cautious: Trupanion had an average “Hold” rating and a $40 average price target. Insiders sold 51,605 shares worth about $1.73 million over the last quarter.
  • Interested in Trupanion? Here are five stocks we like better.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) shares gapped up prior to trading on Tuesday. The stock had previously closed at $34.48, but opened at $35.88. Trupanion shares last traded at $35.6260, with a volume of 10,988 shares trading hands.

Analysts Set New Price Targets

TRUP has been the subject of a number of research analyst reports. Stifel Nicolaus increased their target price on shares of Trupanion from $29.00 to $34.00 and gave the company a "hold" rating in a report on Monday, November 9th. Cantor Fitzgerald boosted their price target on Trupanion from $30.00 to $33.00 and gave the stock a "neutral" rating in a research note on Monday, November 9th. Wall Street Zen upgraded Trupanion from a "hold" rating to a "buy" rating in a report on Saturday, November 7th. Zacks Research cut Trupanion from a "strong-buy" rating to a "hold" rating in a report on Monday, August 24th. Finally, Piper Sandler downgraded Trupanion from an "overweight" rating to a "neutral" rating and dropped their price objective for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Trupanion presently has an average rating of "Hold" and an average target price of $40.00.

Check Out Our Latest Research Report on Trupanion

Trupanion Trading Down 0.6%

The company has a debt-to-equity ratio of 0.24, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 58.60, a PEG ratio of 1.58 and a beta of 1.27. The business's 50-day simple moving average is $27.89 and its 200-day simple moving average is $26.77.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.04. Trupanion had a return on equity of 6.71% and a net margin of 1.71%. The firm had revenue of $405.59 million during the quarter, compared to the consensus estimate of $402.53 million. During the same period in the previous year, the firm posted $0.13 EPS. Research analysts predict that Trupanion, Inc. will post 0.68 earnings per share for the current fiscal year.

Insider Buying and Selling at Trupanion

In other Trupanion news, Director Murray B. Low sold 6,537 shares of the business's stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $34.21, for a total transaction of $223,630.77. Following the completion of the sale, the director owned 147,997 shares of the company's stock, valued at approximately $5,062,977.37. The trade was a 4.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO John R. Gallagher sold 3,604 shares of the stock in a transaction on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer owned 33,742 shares of the company's stock, valued at approximately $1,002,137.40. This represents a 9.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 51,605 shares of company stock valued at $1,732,783. Corporate insiders own 5.58% of the company's stock.

Institutional Investors Weigh In On Trupanion

Several hedge funds and other institutional investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new position in Trupanion in the second quarter worth about $134,774,000. Dimensional Fund Advisors LP raised its stake in Trupanion by 15.7% during the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider's stock valued at $17,981,000 after buying an additional 95,064 shares in the last quarter. Bank of America Corp DE acquired a new stake in Trupanion during the second quarter valued at approximately $14,262,000. Goldman Sachs Group Inc. raised its stake in Trupanion by 15.3% during the third quarter. Goldman Sachs Group Inc. now owns 567,313 shares of the financial services provider's stock valued at $13,252,000 after buying an additional 75,442 shares in the last quarter. Finally, Kopion Asset Management LLC lifted its holdings in Trupanion by 30.9% during the 2nd quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider's stock worth $12,955,000 after buying an additional 123,308 shares during the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines